top of page
Search
BULGAR

Ivermectin kontra-ASF, tetestingin

ni Lolet Abania | May 4, 2021




Bumuo ang Department of Agriculture (DA) ng isang research team upang alamin ang potensiyal na maaaring ibigay ng antiparasitic drug na Ivermectin para maiwasan at makontrol ang pagkalat ng African swine fever (ASF).


Sa isang Special Order No. 310, series of 2021, na may petsang April 30, 2021, iniutos ni DA Secretary William Dar na magtatag ng isang research team kung saan tututok sa ASF control and prevention upang maresolbahan ang krisis sa nasabing sakit.


“The research team is tasked to prepare research proposals on the use of Ivermectin, ASF Buster, Cloud Feed and other potential products for the control and prevention of ASF,” ayon sa inilabas na special order ng DA.


“The team is also directed to conduct preliminary field trials of Ivermectin and other agents to produce science-based evidence in support to control and prevention programs of ASF,” dagdag pa ng DA.


Binubuo ang team ng mga technical advisers, kabilang na sina DA Undersecretary William Medrano, National Livestock Program Director Dr. Ruth Miclat-Sonaco, at Bureau of Animal Industry (BAI) officer-in-charge Director Dr. Reildrin Morales.


Inilagay din bilang program leader si BAI OIC-Assistant Director Dr. Rene Santiago habang si Philippine Carabao Center OIC-Deputy Executive Director for Production and Research Dr. Claro Mingala ay assistant program leader.


Ang mga project leaders naman ng research team ay sina National Dairy Authority Deputy Administrator Dr. Farrel Benjelix Magtoto, Pampanga State Agricultural University Associate Professor Dr. Rogelio Carandang, Jr., at BAI Livestock Research and Development Division chief Dr. Marivic de Vera.


Nakasaad pa sa special order na inaatasan ang research team, “to formulate and draft science-based policies for National Guidelines in using Ivermectin and other agents in the control and prevention programs of ASF and collaborate with international research and institution to conduct experiments to support claims in the use of Ivermectin and other agents.”


Matatandaang nagbigay ng matinding atensiyon sa publiko ang Ivermectin dahil sa sinasabing magagamit itong gamot kontra-COVID-19.


Gayunman, hindi pa aprubado ng Food and Drug Administration (FDA) ang pag-inom ng tinatawag na human-grade Ivermectin sa Pilipinas. Ayon sa batas, ang Ivermectin ay maaari lamang i-prescribe sa mga hayop.


Subali't, ang FDA ay nagbigay na ng compassionate use permit para sa paggamit ng Ivermectin sa mga tao laban sa COVID-19 sa limang ospital.


Ayon naman sa FDA, ang pag-isyu nila ng compassionate use permit ay hindi nangangahulugan na ginagarantiya ng ahensiya ang safety at efficacy nito, bagkus, pinayagan lamang nila ito para sa legal administration ng gamot sa bansa.


Samantala, ang resulta ng clinical trials ng Ivermectin bilang treatment sa COVID-19 ng Department of Science and Technology (DOST) ay posibleng lumabas sa Enero 2022.


Comments


Disclaimer : The views and opinions expressed on this website or any comments found on any articles herein, are those of the authors or columnists alike, and do not necessarily reflect nor represent the views and opinions of the owner, the company, the management and the website.

RECOMMENDED
bottom of page